Allogene Therapeutics, Inc. (ALLO): Weighted Average Diluted Shares
220.62M
Year ended 2025-12-31
+15.5%
3-year compound annual growth
+12.9%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 220.62M | +13.2% | 2026-03-12, From 2025-01-01 |
| 2024-12-31 | 194.81M | +24.1% | 2026-03-12, From 2024-01-01 |
| 2023-12-31 | 156.93M | +9.6% | 2025-03-13, From 2023-01-01 |
| 2022-12-31 | 143.15M | +5.4% | 2024-03-14, From 2022-01-01 |
| 2021-12-31 | 135.82M | +12.8% | 2024-03-14, From 2021-01-01 |
| 2020-12-31 | 120.37M | +19.1% | 2024-03-14, From 2020-01-01 |
| 2019-12-31 | 101.06M | n/a | 2022-02-23, From 2019-01-01 |